IP Library › Granted Patent US 7,070,805
Granted Patent B2
US 7,070,805 · App. 09/800,839 · Granted Jul 4, 2006

Rapidly disintegrable solid preparation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,070,805
App. No.
09/800,839
Granted
Jul 4, 2006
Kind
B2
Abstract

A rapidly disintegrable solid preparation which comprises (i) a pharmacologically active ingredient, (ii) a sugar and (iii) a low-substituted hydroxypropylcellulose having 5% by weight or more to less than 7% by weight of hydroxypropoxyl group. The rapidly disintegrable solid preparation has fast disintegrability, suitable strength and no roughness.

Claims (2)

1. An oral rapidly disintegrable solid preparation which comprises (i) manidipine hydrochloride, (ii) a sugar and (iii) a low-substituted hydroxypropylcellulose having 5% by weight or more to less than 7% by weight of hydroxypropoxyl groups; wherein said solid preparation is buccally dissolved in from about 5 to about 50 seconds.

2. An oral rapidly disintegrable solid preparation which comprises (i) pioglitazone hydrochloride, (ii) a sugar and (iii) a low-substituted hydroxypropylcellulose having 5% by weight or more to less than 7% by weight of hydroxypropoxyl groups; wherein said solid preparation is buccally dissolved in from about 5 to about 50 seconds.

Assignments (1)
CHANGE OF NAME Recorded Jun 2, 2005
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 018917/0406 →